搜尋結果
FDA approves GSK's RSV vaccine for high-risk adults ages 50 to 59, expanding shot's reach
CNBC· 1 小時前The Food and Drug Administration on Friday expanded the approval of GSK's respiratory ...
‘Democracy Discount’ In Indian Movie Theaters
Forbes· 2 日前RS Durai Senthilkumar’s Tamil film Garudan has managed to score $3 million in five days at the ...
What To Know About Personalized mRNA Cancer Vaccines After Promising Trials From Moderna And Merck
Forbes· 4 日前Cancer vaccines are finally showing promise as Moderna and Merck touted promising data on an ...
British sandwich chain Pret abandons plan to open in Israel
Reuters· 4 日前The retailer, owned by investment firm JAB and founder Sinclair Beecham, signed an agreement ...
Wilder succumbs to Big Bang's theory
China Daily· 4 日前Raw Chinese power shook the new capital of world boxing, as heavyweight star Zhang Zhilei threw down the gauntlet to the ...
Seasonal flu jabs hit record high
news.gov.hk· 5 日前The Department of Health today said over 1.86 million doses of the seasonal influenza vaccination (SIV) were administered ...
Rapper BIA Accuses Cardi B Of Cheating On Husband Offset In Diss Track: What To Know About ...
Forbes· 5 日前In a season increasingly defined by high-profile rap feuds, rapper BIA released her diss track ...
加科思(01167.HK)在ASCO大會口頭報告兩項臨床數據
AASTOCKS via Yahoo財經香港· 5 日前從有效性數據來看，一線非小細胞肺癌患者共入組102例，分佈在7個劑量組，確認客觀緩解率為64.7%，疾病控制率為93.1%；從安全性資料來看，在194例患者中，三 ...
加科思(01167)以口頭報告形式在ASCO大會上公布兩項臨床數據
infocast via Yahoo財經香港· 6 日前Glecirasib與JAB-3312聯合用藥目前已在中國啟動KRAS G12C突變的一線非小細胞肺癌臨床三期試驗。Glecirasib單藥用於KRAS G12C突變二線非小細胞肺癌的新藥上 ...
Chinese cell therapy may treat asthma long term with a single jab: study
South China Morning Post· 6 日前Cytokines are signalling proteins that help control inflammation in the body, but too many ...
